Skip to Main Content

Paper Details

Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial.
J Immunother Cancer
12
2022
Author NameAffiliation
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2